期刊
ANNALS OF NEUROLOGY
卷 59, 期 2, 页码 237-247出版社
WILEY
DOI: 10.1002/ana.20786
关键词
-
资金
- NIDA NIH HHS [K08 DA016160, K08 DA016160-03, K08DA016160] Funding Source: Medline
- NIGMS NIH HHS [R01GM64402] Funding Source: Medline
- NIMH NIH HHS [P01MH070056] Funding Source: Medline
- NINDS NIH HHS [R01NS043990] Funding Source: Medline
Objective: The diagnosis of multiple sclerosis (MS) can be challenging because of the lack of a specific diagnostic test. Recent advances in proteomics, however, offer new opportunities for biomarker discovery and the study of disease pathogenesis. Methods: We analyzed cerebrospinal fluid (CSF) samples from 29 patients with MS or clinically isolated syndromes (CIS), 27 patients with transverse myelitis (TM), 50 patients with human immunodeficiency virus (HIV) infection, and 27 patients with other neurological diseases (ONDs) by surface-enhanced laser desorption/ionization time-of-flight mass spectroscopy. Results. We found a unique protein of 12.5kDa that was 100% specific for MS/CIS compared with TM or OND. Low levels of this protein were found in some patients with HIV infection. Tandem mass spectroscopy of a tryptic digest of this 12.5kDa protein identified it as a cleavage product of full-length cystatin C (13.4kDa), an important inhibitor of cysteine proteases including the cathepsins. Although total cystatin C levels in the MS patients was not different compared with controls, the patients with the highest 12.5/13.4 peak ratios also had the greatest cathepsin B inhibitory activity. Interpretation: This suggests that cleavage of cystatin C may be an adaptive host response and may identify a subgroup of patients with MS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据